Intecept Pharmaceuticals misses

Intercept Pharmaceuticals Inc. (Nasdaq: ICPT) reported a wider than expected loss for the third quarter sending the stock price plummeting $74.39 to close at $172.59.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.